Ratings by LifeSci Capital
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 3/26/2024 | Rami Katkhuda | Mineralys Therapeutics, Inc. | MLYS | Downgrade | Outperform (N/A) |
33.00 (N/A) |
12.92 (11.36) |
-12.07% | Details |
| 2/28/2024 | N/A | Ventyx Biosciences Inc | VTYX | Upgrade | Outperform (Market Perform) |
5.00 (N/A) |
6.05 (4.24) |
-29.92% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 5 more... | |||||||||
